• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Verastem Data Shows 2-Year Follow-Up for Combo Therapy

    BUSINESSWIRE

    Verastem Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    BUSINESSWIRE

    Verastem Oncology to Report Q4 and FY 2025 Results on March 4

    BUSINESSWIRE

    Verastem Updates RAMP 203 Trial for KRAS G12C+ NSCLC

    BUSINESSWIRE

    Verastem Oncology To Present At Evercore Healthcare Conference

    BUSINESSWIRE

    Verastem Oncology Prices $90M Public Stock Offering & Warrants

    BUSINESSWIRE

    Verastem Oncology To Present at Upcoming Investor Conferences

    BUSINESS WIRE

    Verastem Oncology Reveals Q3 2025 Financials & Business

    BUSINESSWIRE

    Verastem Oncology Reports Data From Phase 1/2a Trial of VS-7375

    BUSINESSWIRE

    Verastem, GenFleet Report GFH375 Ph1/2 KRAS G12D Pancreatic Data

    BUSINESSWIRE

    Verastem, GenFleet GFH375 Data in Lung Cancer at IASLC 2025

    BUSINESSWIRE

    Verastem Oncology`s Q2 Financial Results and Business Updates

    BUSINESSWIRE

    FDA grants Fast Track to Verastem Oncology`s VS-7375

    CONTRACTPHARMA

    Harvard Bioscience Names New CEO, Adds Two Independent Directors

    GLOBENEWSWIRE

    Verastem’s RAMP 201 Results Published for Ovarian Cancer Combo

    BUSINESSWIRE

    Verastem Oncology Announces First Patient Dosed with VS-7375

    BUSINESSWIRE

    Verastem Oncology Reports Positive Results from RAMP 205 Study

    BUSINESSWIRE

    Verastem Oncology Announces U.S. IND Clearance for VS-7375, Oral

    BUSINESSWIRE

    Verastem to Present at Guggenheim SMID Cap Biotech Conference

    BUSINESSWIRE

    Verastem and STAAR Launch Low-Grade Serous Ovarian Cancer Awareness Day

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.